Skip to content

A Study of Yoga Therapy in schizophrenia

Yoga and Schizophrenia - A Comprehensive Assessment of Neuroplasticity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009219
Enrollment
240
Registered
2017-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Schizophrenia

Interventions

Intervention1: Yoga module: Validated Yoga Module for Schizophrenia with duration approximately 60 minutes adapted from the Integrated approach of yoga therapy for positive health Control Interventio

Sponsors

Wellcome TrustDBT India Alliance
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of schizophrenia (DSM V) Clinical Global Impression â?? Severity (CGI-S) Score equal to or more than 3 Age range 18 to 45 years Both sexes Written informed consent

Exclusion criteria

Exclusion criteria: Risk of harm to self (for example suicidal risk) or others (for example aggression). Need for Electroconvulsive therapy Subjects who are already practicing/ recent practice of yoga/ meditation. Co-morbid substance dependence in the past 6 months or substance abuse in the past 1 month as per DSM V, except nicotine. Significant neurological disorder including seizure disorder or recent head injury. Family history of neurological disorder that may complicate diagnosis (for example Huntingtonâ??s chorea) Pregnancy or postpartum (6 weeks after delivery)

Design outcomes

Primary

MeasureTime frame
Positive and Negative Symptoms of Schizophrenia Social cognition Serum BDNF, Plasma oxytocin levels Neuroimaging parametersTimepoint: Baseline 1 month 3 months 6 months

Secondary

MeasureTime frame
Quality of life, Perceived stress levels Sociooccupational functioning. Serum Cortisol and Serum IGF1 Expression of BDNF and oxytocin gene in peripheral lymphocytesTimepoint: Baseline 1 month 3 months 6 months

Countries

India

Contacts

Public ContactDr Shivarama Varambally

National Institute of Mental Health and Neurosciences

ssv.nimhans@gmail.com9480829484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 20, 2026